However, stringent government regulations is major factor restraining growth of the global androstenedione market. For instance, androstenedione is banned by the World Anti-Doping Agency (WADA) and International Olympic Committee (IOC), under the category of androgenic anabolic steroids. However, adverse effects of androstenedione include sustained increase in serum estrogen and increase in serum luteinizing hormone, lean muscle mass, and bone growth problem in children, thus restraining growth of the global androstenedione market. Furthermore, pregnant women are warned from using these pills as they are linked with higher risks of labor and cause of miscarriage.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients